Binding of 14C-misonidazole to hypoxic cells in V79 spheroids
- PMID: 7082555
- PMCID: PMC2011024
- DOI: 10.1038/bjc.1982.110
Binding of 14C-misonidazole to hypoxic cells in V79 spheroids
Abstract
The metabolism-induced binding of 14C-labelled misonidazole (MISO) to hypoxic V79 cells in multicell spheroids has been quantitated using autoradiography. Hypoxia was shown to be the major determinant of the rate of binding. Maximally hypoxic cells bound MISO several times more rapidly than necrotic material in the centre of the spheroids, and up to 50 times more rapidly than well oxygenated cells. The rate of binding to chronically hypoxic cells at the edge of the necrotic centre was 20 times less than to similar cells in other spheroids made maximally hypoxic with N2. This difference is consistent with the greater radio-sensitivity of the chronically hypoxic cells, which is a consequence of their intermediate level of oxygenation. The results indicated that the ability to bind MISO might have considerable potential as a marker for hypoxic cells in tumours. However, some binding patterns cannot be explained by the simplest model of O2 diffusion. It may be necessary to invoke more complex models of O2 diffusion or metabolic gradients within the spheroid which affect the rate of binding.
Similar articles
-
Binding of misonidazole to EMt6 and V79 spheroids.Int J Radiat Oncol Biol Phys. 1982 Mar-Apr;8(3-4):737-9. doi: 10.1016/0360-3016(82)90724-6. Int J Radiat Oncol Biol Phys. 1982. PMID: 7107407
-
Hypoxic fraction and binding of misonidazole in EMT6/Ed multicellular tumor spheroids.Radiat Res. 1985 Jul;103(1):89-97. Radiat Res. 1985. PMID: 4070561
-
Comparison of binding of [3H]misonidazole and [14C]misonidazole in multicell spheroids.Radiat Res. 1985 Mar;101(3):473-9. Radiat Res. 1985. PMID: 3983363
-
Misonidazole and other hypoxia markers: metabolism and applications.Int J Radiat Oncol Biol Phys. 1986 Jul;12(7):1195-202. doi: 10.1016/0360-3016(86)90257-9. Int J Radiat Oncol Biol Phys. 1986. PMID: 3528089 Review.
-
Keynote address: cellular reduction of nitroimidazole drugs: potential for selective chemotherapy and diagnosis of hypoxic cells.Int J Radiat Oncol Biol Phys. 1989 Apr;16(4):911-7. doi: 10.1016/0360-3016(89)90886-9. Int J Radiat Oncol Biol Phys. 1989. PMID: 2649465 Review.
Cited by
-
Binding of misonidazole to hypoxic cells in monolayer and spheroid culture: evidence that a side-chain label is bound as efficiently as a ring label.Br J Cancer. 1985 Feb;51(2):229-35. doi: 10.1038/bjc.1985.33. Br J Cancer. 1985. PMID: 3966980 Free PMC article.
-
The role of necrosis, acute hypoxia and chronic hypoxia in 18F-FMISO PET image contrast: a computational modelling study.Phys Med Biol. 2016 Dec 21;61(24):8596-8624. doi: 10.1088/1361-6560/61/24/8596. Epub 2016 Nov 23. Phys Med Biol. 2016. PMID: 27880734 Free PMC article.
-
Distribution and tumor penetration properties of a radiosensitizer 2-[14C] misonidazole (Ro 07-0582), in mice and rats as studied by whole-body autoradiography.Cancer Chemother Pharmacol. 1986;17(2):121-6. doi: 10.1007/BF00306739. Cancer Chemother Pharmacol. 1986. PMID: 3719893
-
Pharmacokinetics and binding of the bioreductive probe for hypoxia, NITP: effect of route of administration.Br J Cancer. 1995 Dec;72(6):1462-8. doi: 10.1038/bjc.1995.530. Br J Cancer. 1995. PMID: 8519660 Free PMC article.
-
Hypoxia imaging and radiotherapy: bridging the resolution gap.Br J Radiol. 2017 Aug;90(1076):20160939. doi: 10.1259/bjr.20160939. Epub 2017 May 25. Br J Radiol. 2017. PMID: 28540739 Free PMC article. Review.
References
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources